João José Cerqueira (JJC) is associate professor of neurology (with habilitation) and course director at the School of Medicine and principal investigator at ICVS/3B’s research institute, University of Minho, in Braga, Portugal. He is also head of the neuroimmunology clinic at Hospital de Braga and medical executive director of the 2CA – Braga, a Clinical Academic Centre fully devoted to clinical research and the number one site for clinical trials in Portugal. João’s research focuses on determinants and treatment of poor cognitive function, particularly in neuroimmune disorders. He is the author of more than 90 peer reviewed papers, with more than 2500 citations (h index 26). His work has been funded by Portuguese Science Foundation, European Union, BIAL Foundation and BIOGEN. He co-supervised 5 PhD and 6 Master students.
João José Cerqueira (JJC) is associate professor of neurology (with habilitation) and course director at the School of Medicine and principal investigator at ICVS/3B’s research institute, University of Minho, in Braga, Portugal. He is also head of the neuroimmunology clinic at Hospital de Braga and medical executive director of the 2CA – Braga, a Clinical Academic Centre fully devoted to clinical research and the number one site for clinical trials in Portugal. João’s research focuses on determinants and treatment of poor cognitive function, particularly in neuroimmune disorders. He is the author of more than 90 peer reviewed papers, with more than 2500 citations (h index 26). His work has been funded by Portuguese Science Foundation, European Union, BIAL Foundation and BIOGEN. He co-supervised 5 PhD and 6 Master students.
In this encompassing project we aim to explore the determinants of cognitive deficits in patients with multiple sclerosis, contribute to develop and validate patient- and physician-friendly methods for their detection and characterization (CogEval) and test novel treatment strategies…
Frailty is a marker of poor clinical outcomes in healthy ageing but also in several chronic conditions. The objetive of this project is to develop a MS specific frailty…
Recently, we used a MS animal model to perform high-throughput sequencing of astrocytes’ transcriptome during disease progression. Our data shows a surprising up-regulation of glycolytic and tricarboxylic acid (TCA) cycle…
Epstein-Barr virus (EBV) infection is a major risk factor for developing multiple sclerosis (MS). In this study, we will investigate, in people with MS, a specific type of immune cell called CD8+ T lymphocytes, which are essential for controlling viral infections, including EBV.
This project aims to explore the immune system on multiple sclerosis pathophysiology and is divided in 3 branches:
– Tcells@MS. Our recent studies on newly diagnoses RRMS and PPMS patients…
This project builds on previous findings from my group that newly diagnosed, treatment-naive people with multiple sclerosis have fewer memory T cells compared to age- and sex-matched healthy controls.
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
